OverviewChartNewsTraderScreen

Soc. Generale Knock-Out LLY/  DE000SH5Y1L3  /

EUWAX
2024-08-02  9:28:44 AM Chg.-0.16 Bid10:11:02 AM Ask10:11:02 AM Underlying Strike price Expiration date Option type
4.59EUR -3.37% 4.59
Bid Size: 3,000		 4.61
Ask Size: 3,000		 Eli Lilly and Co 320.8704 USD 2078-12-31 Call
TeleTrader 07-08 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 07-02 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 07-01 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 06-28 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 06-25 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 06-21 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 06-17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 06-17 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 06-14 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 06-11 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 06-10 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 06-10 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06-06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 06-05 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 06-03 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost
TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 05-13 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...
GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results